Title : Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes.

Pub. Date : 2005 Jun

PMID : 15957976






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Enoxaparin (Lovenox; Roule-Poulenc Rorer, Inc.), a low molecular weight heparin (LMWH), is commonly used in the management of non-ST-segment elevation acute coronary syndromes (NSTE ACS) based on clinical trial outcomes. Enoxaparin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens
2 Enoxaparin (Lovenox; Roule-Poulenc Rorer, Inc.), a low molecular weight heparin (LMWH), is commonly used in the management of non-ST-segment elevation acute coronary syndromes (NSTE ACS) based on clinical trial outcomes. Enoxaparin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens
3 In a recent systematic overview of > 20,000 patients with NSTE ACS from six clinical trials, including conservative and invasively managed patients, enoxaparin provided a statistically significant reduction in 30-day death or nonfatal myocardial infarction (MI) compared with UFH with no significant excess in transfusions, or major bleeding. Enoxaparin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens
4 These data support the role of enoxaparin as an anti-coagulant in patients with NSTE ACS. Enoxaparin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens